KiraGen Bio
PrivateLast Round
Accelerator
Apr 23, 2025
Company Overview
KiraGen Bio, founded in October 2023, is a biotechnology company pioneering the development of multiplex gene-edited CAR-T cell therapies for solid tumors. The company's proprietary AI-driven platform, KiraLOGIC, systematically designs synergistic gene edits to engineer CAR-T cells that can resist the suppressive tumor microenvironment (TME), a major barrier to efficacy in solid tumors like glioblastoma, their lead program. Co-founded by experts from bluebird bio and Beam Therapeutics, KiraGen Bio aims to create durable, "off-the-shelf" cell therapies that are more accessible and affordable. The company has secured pre-seed funding from several venture capital firms and is actively advancing its therapies toward clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KiraGen Bio Comps
Public and private peers based on sector, stage, and business model.
KiraGen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 23, 2025 | ||||
| Pre Seed | Mar 20, 2025 |
Key People
Founding team and executive leadership
KiraGen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Allston Venture Fund | Pre Seed |
| Gaingels | Pre Seed |
| ZAKA VC | Pre Seed |
| Conscience VC | Pre Seed |
| Phoenix Investment Club | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2025
Featured on The Sheekey Science Show.
- Feb 18, 2025
Advanced to the Boston Regional Finals of the HBS New Venture Competition.
KiraGen Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KiraGen Bio's valuation, stock price, and market status.
